Adipose insulin resistance is associated with cardiovascular risk factors in polycystic ovary syndrome

被引:21
作者
Mu, L. [1 ,2 ,3 ,4 ]
Li, R. [1 ,2 ,3 ]
Lai, Y. [1 ,5 ]
Zhao, Y. [1 ,2 ,4 ]
Qiao, J. [1 ,2 ,3 ,4 ,5 ]
机构
[1] Peking Univ, Dept Obstet & Gynecol, Ctr Reprod Med, Hosp 3, 49 North HuaYuan Rd, Beijing 100191, Peoples R China
[2] Natl Clin Res Ctr Obstet & Gynecol, Beijing 100191, Peoples R China
[3] Beijing Key Lab Reprod Endocrinol & Assisted Repr, Beijing 100191, Peoples R China
[4] Minist Educ, Key Lab Assisted Reprod, Beijing 100191, Peoples R China
[5] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China
基金
中国国家自然科学基金;
关键词
Polycystic ovary syndrome; Adipose tissue; Insulin resistance; Metabolic syndrome; GLUCOSE-PRODUCTION; INFLAMMATION; PREVALENCE; OBESE; PATHOPHYSIOLOGY; SENSITIVITY; STRESS; WOMEN;
D O I
10.1007/s40618-018-0949-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PurposeThe effects of adipose insulin resistance on cardiovascular risk factors in polycystic ovary syndrome (PCOS) remain largely unknown. We aimed to investigate associations between adipose insulin resistance and cardiovascular risk factors in PCOS.MethodsA total of 207 PCOS and 47 non-PCOS women were recruited from a large reproductive medicine center in this cross-sectional study. The PCOS diagnosis was based on the Rotterdam Criteria. The subjects received a standard oral glucose tolerance test. Adipose insulin resistance was evaluated using a validated index (adipose-IR=fasting insulinxfree fatty acid concentrations).ResultsThe women with PCOS showed a higher adipose-IR index, and the adipose-IR index was tightly associated with the blood pressure, glucose and lipid parameters. A total of 98.0% of the women with PCOS in the highest adipose-IR quartile showed cardiovascular risk factors (obesity, hypertension, glucose intolerance or dyslipidemia), and this percentage was significantly higher than the percentage of those in the lowest quartile (32.7%). In addition, the percentages of women with three (31.4%) and four (13.7%) cardiovascular risk factors were significantly elevated in the highest adipose-IR quartile. The multivariable logistic regression analysis indicated that each 1-SD increment in the adipose-IR index resulted in higher risks of obesity (OR=3.18, 95% CI=2.12-4.76), hypertension (OR=1.89, 95% CI=1.31-2.73), glucose intolerance (OR=2.45, 95% CI=1.73-3.48), and dyslipidemia (OR=2.18, 95% CI=1.57-3.01). The C-reactive protein (CRP) level was positively associated with the adipose-IR index in women with PCOS (r=0.45, P<0.001).ConclusionsThe adipose-IR index was associated with cardiovascular risk factors in women with PCOS. Chronic inflammation may induce insulin resistance in the adipose tissue of women with PCOS.
引用
收藏
页码:541 / 548
页数:8
相关论文
共 50 条
  • [31] Genetics of insulin resistance in polycystic ovary syndrome
    Obermayer-Pietsch, Barbara
    Trummer, Christian
    Schwetz, Verena
    Schweighofer, Natascha
    Pieber, Thomas
    CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2015, 18 (04) : 401 - 406
  • [32] Elevated fasting insulin is associated with cardiovascular and metabolic risk in women with polycystic ovary syndrome
    Rasool, Shayaq Ul Abeer
    Ashraf, Sairish
    Nabi, Mudasar
    Rashid, Fouzia
    Fazili, Khalid Majid
    Amin, Shajrul
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (03) : 2098 - 2105
  • [33] Insulin resistance, dyslipidemia, and metabolic syndrome in women with polycystic ovary syndrome
    El-Mazny, Akmal
    Abou-Salem, Nermeen
    El-Sherbiny, Walid
    El-Mazny, Ahmed
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2010, 109 (03) : 239 - 241
  • [34] Central Obesity Index and Cardiovascular Risk Factors in Polycystic Ovary Syndrome
    Costa, Eduardo Caldas
    Mafaldo Soares, Elvira Maria
    Araujo Moura Lemos, Telma Maria
    de Oliveira Maranhao, Tecia Maria
    Azevedo, George Dantas
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2010, 94 (05) : 633 - 638
  • [35] Are polycystic ovaries associated with cardiovascular disease risk as polycystic ovary syndrome?
    Engin-Uestuen, Yaprak
    Ustun, Yusuf
    Meydanli, M. Mutlu
    Kafkasli, Ayse
    Yetkin, Guelay
    GYNECOLOGICAL ENDOCRINOLOGY, 2006, 22 (06) : 324 - 328
  • [36] Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome
    Tziomalos, Konstantinos
    Katsikis, Ilias
    Papadakis, Efstathios
    Kandaraki, Eleni A.
    Macut, Djuro
    Panidis, Dimitrios
    HUMAN REPRODUCTION, 2013, 28 (03) : 785 - 793
  • [37] Polycystic ovary syndrome and adipose tissue
    Lemaitre, Madleen
    Christin-Maitre, Sophie
    Kerlan, Veronique
    ANNALES D ENDOCRINOLOGIE, 2023, 84 (02) : 308 - 315
  • [38] Is Insulin Resistance an Intrinsic Defect in Asian Polycystic Ovary Syndrome?
    Lee, Hyejin
    Oh, Jee-Young
    Sung, Yeon-Ah
    Chung, Hyewon
    YONSEI MEDICAL JOURNAL, 2013, 54 (03) : 609 - 614
  • [39] Cardiovascular risk markers in polycystic ovary syndrome in women with and without insulin resistance
    Martins, Wellington de Paula
    Soares, Gustavo Mafaldo
    Vieira, Carolina Sales
    dos Reis, Rosana Maria
    Silva de Sa, Marcos Felipe
    Ferriani, Rui Alberto
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2009, 31 (03): : 111 - 116
  • [40] A New Predictor for Insulin Resistance in Polycystic Ovary Syndrome: InsuTAG
    Omma, Tulay
    Gokce, Aksanur
    Celik, Mustafa
    Karahan, Irfan
    Culha, Cavit
    Gulcelik, Nese Ersoz
    CURRENT WOMENS HEALTH REVIEWS, 2024, 20 (02)